Following in the footsteps of Gilead Sciences, Merck & Co. has signed voluntary licensing agreements to enable access to its investigational HIV PrEP pill alimatravir. The New Jersey pharma is ...

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced early components of a multi-faceted strategy to provide rapid, broad and sustainable access in low- and ...

Several interconnecting barriers continue to hinder PrEP access and exacerbate HIV prevention disparities.

Friday marks the 35th anniversary of World AIDS Day, an international moment to remember, reflect and educate people on the HIV/AIDS epidemic that started over four decades ago. But due to ...

HIV prevention was allocated A$43.9 million over three years in this week's federal budget. Some $26m of this is for "PrEP" for people without access to Medicare. PrEP means pre-exposure ...

The US Preventive Services Task Force (USPSTF) has recommended that clinicians prescribe pre-exposure prophylaxis (PrEP) to decrease the risk of acquiring HIV. There are approximately 1.2 million ...

Sara Moniuszko is a health and lifestyle reporter at CBSNews.com. Previously, she wrote for USA Today, where she was selected to help launch the newspaper's wellness vertical. She now covers breaking ...

Alexis Perkins thought her OB-GYN's office in Atlanta would be just the place to get a prescription for the type of drug that reduces a person's risk of contracting HIV. But during a recent visit, the ...

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. A new pre-exposure prophylaxis (PrEP) drug has shown promise as a ...

The US Preventive Services Task Force recently issued a recommendation statement for preexposure prophylaxis (PrEP) for HIV, but it is so broadly worded that it will be subject to vast payer ...

Under Trump, the global fight against HIV is running on fumes.